Hendra virus: a one health tale of flying foxes, horses and humans

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Selvey LA, Wells RM, McCormack JG et al. Infection of humans and horses by a newly described morbillivirus. Med. J. Aust.162(12),642–645 (1995).▪ Describes the initial 1994 outbreak of this previously unrecognized viral infection, with details of the equine and human cases.
  Medline CASGoogle Scholar
• 2  Tulsiani SM, Graham GC, Moore PR et al. Emerging tropical diseases in Australia. Part 5. Hendra virus. Ann. Trop. Med. Parasitol.105(1),1–11 (2011).
  Medline CASGoogle Scholar
• 3  Murray K, Selleck P, Hooper P et al. A morbillivirus that caused fatal disease in horses and humans. Science268,94–97 (1995).
  Medline CASGoogle Scholar
• 4  Wang L-F, Yu M, Hansson E et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J. Virol.74(21),9972–9979 (2000).
  Medline CASGoogle Scholar
• 5  Marsh GA, de Jong C, Barr JA et al. Cedar virus: a novel henipavirus isolated from Australian bats. PLoS Pathog.8,e1002836 (2012).
  Medline CASGoogle Scholar
• 6  Breed AC, Breed MF, Meers J, Field HE. Evidence of endemic Hendra virus infection in flying-foxes (Pteropus conspicillatus) – implications for disease risk management. PLoS ONE6(12),e28816 (2011).
  Medline CASGoogle Scholar
• 7  Mahalingam S, Herrero LJ, Playford EG et al. Hendra virus: an emerging paramyxovirus in Australia. Lancet Infect. Dis.12(10),799–807 (2012).
  MedlineGoogle Scholar
• 8  Plowright RK, Foley P, Field HE et al. Urban habituation, ecological connectivity and epidemic dampening: the emergence of Hendra virus from flying foxes (Pteropus spp.). Proc. R. Soc. B278(1725),3703–3712 (2011).▪ Describes some of the ecological factors, namely urban habituation of pteropid bats and their reduced migratory activity, which contribute to Hendra virus (HeV) spillover events.
  MedlineGoogle Scholar
• 9  Field H, de Jong C, Melville D et al. Hendra virus infection dynamics in Australian fruit bats. PLoS ONE6,e28678 (2011).
  Medline CASGoogle Scholar
• 10  Halpin K, Hyatt AD, Fogarty R et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am. J. Trop. Med. Hyg.85(5),946–951 (2011).
  MedlineGoogle Scholar
• 11  Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses. Microbes Infect.3(4),307–314 (2001).
  Medline CASGoogle Scholar
• 12  Hess IMR, Massey PD, Walker B, Middleton DJ, Wright TM. Hendra virus: what do we know? NSW Public Health Bull.22(5–6),118–122 (2011).
  MedlineGoogle Scholar
• 13  Marsh GA, Haining J, Hancock TJ et al. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands. Emerg. Infect. Dis.17(12),2232–2238 (2011).
  MedlineGoogle Scholar
• 14  Fogarty R, Halpin K, Hyatt AD, Daszak P, Mungall BA. Henipavirus susceptibility to environmental variables. Virus Res.132(1–2),140–144 (2008).
  Medline CASGoogle Scholar
• 15  Playford EG, McCall B, Smith G et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg. Infect. Dis.16,219–223 (2010).▪ Describes the 2008 HeV outbreak in a Queensland, Australia, veterinary clinic, resulting in two human infections. Variability in equine presentation and probable horse-to-human transmission occurring in the late incubation period are highlighted.
  MedlineGoogle Scholar
• 16  Selvey L, Taylor R, Arklay A, Gerrard J. Screening of bat carers for antibodies to equine morbillivirus. Commun. Dis. Intell.20(22),477–478 (1996).
  Google Scholar
• 17  Dups J, Middleton D, Yamada M et al. A new model for Hendra virus encephalitis in the mouse. PLoS ONE7(7),e40308 (2012).
  Medline CASGoogle Scholar
• 18  Weingartl HM, Berhane Y, Czub M. Animal models of henipavirus infection: a review. Vet. J.181(3),211–220 (2009).
  MedlineGoogle Scholar
• 19  Li M, Embury-Hyatt C, Weingartl HM. Experimental inoculation study indicates swine as a potential host for Hendra virus. Vet. Res.41(3),33 (2010).
  MedlineGoogle Scholar
• 20  Hyatt AD, Zaki SR, Goldsmith CS, Wise TG, Hengstberger SG. Ultrastructure of Hendra virus and Nipah virus within cultured cells and host animals. Microbes Infect.3(4),297–306 (2001).
  Medline CASGoogle Scholar
• 21  Rollin PE, Rota PA, Zaki S, Ksiazek TG. Hendra and Nipah viruses. In: Manual of Clinical Microbiology (10th Edition). Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (Eds). ASM Press, Washington, DC, USA, 1479–1487 (2011).
  Google Scholar
• 22  Wang L, Harcourt BH, Yu M et al. Molecular biology of Hendra and Nipah viruses. Microbes Infect.3(4),279–287 (2001).
  Medline CASGoogle Scholar
• 23  Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J. Gen. Virol.81(Pt 8),1927–1932 (2000).
  Medline CASGoogle Scholar
• 24  Eaton BT, Broder CC, Middleton D, Wang L-F. Hendra and Nipah viruses: different and dangerous. Nat. Rev. Microbiol.4(1),23–35 (2006).
  Medline CASGoogle Scholar
• 25  Bossart KN, Wang L-F, Eaton BT, Broder CC. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology290(1),121–135 (2001).
  Medline CASGoogle Scholar
• 26  Park MS, Shaw ML, Munoz-Jordan J et al. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol.77(2),1501–1511 (2003).
  Medline CASGoogle Scholar
• 27  Rodriguez JJ, Parisien JP, Horvath CM. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol.76(22),11467–11483 (2002).
  Google Scholar
• 28  Bishop KA, Stantchev TS, Hickey AC et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J. Virol.81(11),5893–5901 (2007).
  Medline CASGoogle Scholar
• 29  Bossart KN, Broder CC. Developments toward effective treatments for Nipah and Hendra virus infection. Expert Rev. Anti Infect. Ther.4(1),43–55 (2006).
  Medline CASGoogle Scholar
• 30  Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J. Virol.84(12),6208–6217 (2010).
  Medline CASGoogle Scholar
• 31  Pernet O, Wang YE, Lee B. Henipavirus receptor usage and tropism. Curr. Top. Microbiol. Immunol.359,59–78 (2012).▪ Reviews the biology of Henipavirus receptors and how receptor usage relates to cell tropism in vitro and in vivo.
  Medline CASGoogle Scholar
• 32  Mackenzie JS, Field HE. Emerging encephalitogenic viruses: lyssaviruses and henipaviruses transmitted by frugivorous bats. Arch. Virol. Suppl.18,97–111 (2004).
  MedlineGoogle Scholar
• 33  Wong KT, Tan CT. Clinical and pathological manifestations of human henipavirus infection. Curr. Top. Microbiol. Immunol.359,95–104 (2012).▪ Reviews the clinicopathological features of HeV and Nipah virus infections.
  Medline CASGoogle Scholar
• 34  Wong KT, Robertson T, Ong BB et al. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol. Appl. Neurobiol.35(3),296–305 (2009).
  Medline CASGoogle Scholar
• 35  Field H, Schaaf K, Kung N et al. Hendra virus infection with novel clinical features, Australia. Emerg. Infect. Dis.16(2),338–340 (2010).
  MedlineGoogle Scholar
• 36  Hanna JN, McBride WJ, Brookes DL et al. Hendra virus infection in a veterinarian. Med. J. Aust.185(10),562–564 (2006).
  MedlineGoogle Scholar
• 37  Taylor C, Playford EG, McBride WJH, McMahon J, Warrilow D. No evidence of prolonged Hendra virus shedding by 2 patients, Australia. Emerg. Infect. Dis.18(12),2025–2027 (2012).
  MedlineGoogle Scholar
• 38  O’Sullivan JD, Allworth AM, Paterson DL et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet349(9045),93–95 (1997).
  MedlineGoogle Scholar
• 39  Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect.3(4),289–295 (2001).▪ Summarizes available diagnostic modalities for HeV and Nipah virus infection.
  Medline CASGoogle Scholar
• 40  Smith IL, Haplin K, Warrilow D, Smith GA. Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus. J. Virol. Methods98(1),33–40 (2001).
  Medline CASGoogle Scholar
• 41  Feldman KS, Foord A, Heine HG et al. Design and evaluation of consensus PCR assays for henipaviruses. J. Virol. Methods161(1),52–57 (2009).
  Medline CASGoogle Scholar
• 42  Foord AJ, Middleton D, Heine HG. Hendra virus detection using loop-mediated isothermal amplification. J. Virol. Methods181(1),93–96 (2012).
  Medline CASGoogle Scholar
• 43  Smith I, Broos A, de Jong C et al. Identifying Hendra virus diversity in pteropid bats. PLoS ONE6(9),e25275 (2011).
  Medline CASGoogle Scholar
• 44  Wang L-F, Daniels P. Diagnosis of henipavirus infection: current capabilities and future directions. Curr. Top. Microbiol. Immunol.359,179–196 (2012).
  Medline CASGoogle Scholar
• 45  Dukes JP, King DP, Alexandersen S. Novel reverse transcription loop-mediated isothermal amplification for rapid detection of foot-and-mouth disease virus. Arch. Virol.151(6),1093–1106 (2006).
  Medline CASGoogle Scholar
• 46  Kaku Y, Noguchi A, Marsh GA et al. Antigen capture ELISA system for henipaviruses using polyclonal antibodies obtained by DNA immunization. Arch. Virol.157(8),1605–1609 (2012).
  Medline CASGoogle Scholar
• 47  Chiang CF, Lo MK, Rota PA, Spiropoulou CF, Rollin PE. Use of monoclonal antibodies against Hendra and Nipah viruses in antigen capture ELISA. Virol. J.7,115 (2010).
  MedlineGoogle Scholar
• 48  Crameri G, Wang L-F, Morrissy C, White J, Eaton BT. A rapid immune plaque assay for the detection of Hendra and Nipah viruses and anti-virus antibodies. J. Virol. Methods99(1–2),41–51 (2002).
  Medline CASGoogle Scholar
• 49  Kaku Y, Noguchi A, Marsh GA et al. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein. J. Virol. Methods160(1–2),7–13 (2009).
  Medline CASGoogle Scholar
• 50  Barclay AJ, Paton DJ. Hendra (equine morbillivirus). Vet. J.160(3),169–176 (2000).
  Medline CASGoogle Scholar
• 51  Rockx B, Bossart KN, Feldmann F et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J. Virol.84(19),9831–9839 (2010).
  Medline CASGoogle Scholar
• 52  Broder CC. Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr. Opin. Virol.2(2),176–187 (2012).
  MedlineGoogle Scholar
• 53  Chong H-T, Kamarulzaman A, Tan C-T et al. Treatment of acute Nipah encephalitis with ribavirin. Ann. Neurol.49(6),810–813 (2001).
  Medline CASGoogle Scholar
• 54  Wright PJ, Crameri G, Eaton BT. RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR or RNA accumulation, the effect of ribavirin and the attenuation of transcription. Arch. Virol.150(3),521–532 (2005).
  Medline CASGoogle Scholar
• 55  Porotto M, Orefice G, Yokoyama CC et al. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. J. Virol.83(10),5148–5155 (2009).
  Medline CASGoogle Scholar
• 56  Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. J. Gen. Virol.91(Pt 3),765–772 (2010).
  Medline CASGoogle Scholar
• 57  Pallister J, Middleton D, Crameri G et al. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. J. Virol.83(22),11979–11982 (2009).
  Medline CASGoogle Scholar
• 58  Georges-Courbot MC, Contamin H, Faure C et al. Poly(I)–poly(C₁₂U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob. Agents Chemother.50(5),1768–1772 (2006).▪ Demonstrates the efficacy of poly(I)–poly(C12U) in the prevention of Nipah virus infection-associated mortality in the hamster model. Ribavirin delayed clinical onset of disease, but did not protect against mortality in this trial.
  Medline CASGoogle Scholar
• 59  Bossart KN, Broder CC. Developments toward effective treatments for Nipah and Hendra virus infection. Expert Rev. Anti Infect. Ther.4(1),43–55 (2006).
  Medline CASGoogle Scholar
• 60  Porotto M, Doctor L, Carta P et al. Inhibition of Hendra virus fusion. J. Virol.80(19),9837–9849 (2006).
  Medline CASGoogle Scholar
• 61  Porotto M, Rockx B, Yokoyama CC et al. Inhibition of Nipah virus infection in vivo: targeting an early stage of Paramyxovirus fusion activation during viral entry. PLoS Pathog.6(10),e1001168 (2010).
  MedlineGoogle Scholar
• 62  Zhu Z, Bossart KN, Bishop KA et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J. Infect. Dis.197(6),846–853 (2008).
  Medline CASGoogle Scholar
• 63  Bossart KN, Zhu Z, Middleton D et al. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog.5(10),e1000642 (2009).
  MedlineGoogle Scholar
• 64  Bossart KN, Geisbert TW, Feldmann H et al. A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci. Transl. Med.3(105),105ra103 (2011).▪▪ Demonstrates the efficacy of postexposure administration of the monoclonal antibody m102.4 in African green monkeys exposed to HeV.
  MedlineGoogle Scholar
• 65  Plowright RK, Field HE, Smith C et al. Reproduction and nutritional stress are risk factors for Hendra virus infection in little red flying foxes (Pteropus scapulatus). Proc. Biol. Sci.275(1636),861–869 (2008).
  MedlineGoogle Scholar
• 66  Pallister J, Middleton D, Wang L-F et al. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine29(34),5623–5630 (2011).
  Medline CASGoogle Scholar
• 67  Mungall BA, Middleton D, Crameri G et al. Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J. Virol.80(24),12293–12302 (2006).
  Medline CASGoogle Scholar
• 68  McEachern JA, Bingham J, Crameri G et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine26(31),3842–3852 (2008).
  Medline CASGoogle Scholar
• 69  Tan CT, Goh KJ, Wong KT et al. Relapsed and late-onset Nipah encephalitis. Ann. Neurol.51(6),703–708 (2002).
  MedlineGoogle Scholar
• 70  Mendez DH, Judd J, Speare R. Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia. Emerg. Infect. Dis.18(1),83–85 (2012).
  MedlineGoogle Scholar
• 101  Queensland Government: Department of Agriculture, Fisheries and Forestry. What is Hendra virus? www.daff.qld.gov.au/4790_15093.htm (Accessed 16 November 2012)
  Google Scholar
• 102  Queensland Government: Department of Agriculture, Fisheries and Forestry. News release, 26 July 2011: Hendra virus infection confirmed in a dog. www.daff.qld.gov.au/30_20717.htm (Accessed 23 November 2012)
  Google Scholar
• 103  Queensland Government: Department of Agriculture, Fisheries and Forestry. Signs of Hendra virus in horses. www.daff.qld.gov.au/4790_20805.htm (Accessed 23 November 2012)
  Google Scholar
• 104  Animal Health Australia. Response policy briefs (Version 3.3). Australian Veterinary Emergency Plan (AUSVETPLAN), Edition 3, Primary Industries Ministerial Council, Canberra, ACT (2009). www.animalhealthaustralia.com.au/wp-content/uploads/2011/04/RPB3_2-02FINAL27Mar09.pdf (Accessed 11 December 2012)
  Google Scholar
• 105  Biosecurity Queensland. Guidelines for veterinarians handling potential Hendra virus infection in horses (Version 4.2). State of Queensland, Department of Employment, Economic Development and Innovation (2011). www.daff.qld.gov.au/documents/Biosecurity_GeneralAnimalHealthPestsAndDiseases/Hendra-GuidelinesForVets.pdf (Accessed 23 November 2012)
  Google Scholar
• 106  ISO 15190:2003 – Medical laboratories – requirements for safety (2004). www.ifcc.org/ifccfiles/docs/150412200405.pdf (Accessed 20 September 2012)
  Google Scholar
• 107  Communicable Diseases Network Australia. Hendra virus national guidelines for public health units. www.commcarelink.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-hendra.htm (Accessed 20 September 2012)
  Google Scholar
• 108  National Pathology Accreditation and Advisory Council (NPAAC). Requirements for the packaging and transport of pathology specimens and associated materials (2007). www.health.gov.au/internet/main/publishing.nsf/Content/health-npaac-publication.htm (Accessed 21 September 2012)
  Google Scholar
• 109  Young J. Queensland Health statement re: monoclonal antibodies. www.health.qld.gov.au/news/media_releases/monoclonal0531.pdf (Accessed 12 December 2012)
  Google Scholar
• 110  University of Queensland: Australian Institute of Bioengineering and Nanotechnology. Hendra virus facts. www.aibn.uq.edu.au/hendra-virus-facts (Accessed 5 February 2013)
  Google Scholar
• 111  Queensland Government: Department of Agriculture, Fisheries and Forestry. Reducing the risk of horses becoming infected with Hendra virus. www.daff.qld.gov.au/4790_20806.htm (Accessed 11 December 2012)
  Google Scholar
• 112  Queensland Government: Department of Agriculture, Fisheries and Forestry. Reducing the risk of people becoming infected with Hendra virus. www.daff.qld.gov.au/4790_20807.htm (Accessed 11 December 2012)
  Google Scholar
• 113  New South Wales Government: Department of Primary Industries. Hendra virus vaccine information for vets. www.dpi.nsw.gov.au/agriculture/livestock/horses/health/general/hendra-virus/vaccine-info-vets (Accessed 4 February 2013)
  Google Scholar